Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jul 13, 2021 8:52am
36 Views
Post# 33534954

RE:lmnl posted another job opening: production technician

RE:lmnl posted another job opening: production technician

Newcamo thinks it's a critical milestone to hire production workers for a plant that they just sold to Kedrion to produce Ryplazim (he posts 30 times a day and still spells it Riplazym for 2 years!). 

The other huge milestone to SURVIVE for Newcamo is getting the $70M voucher money when voucher is sold sometime this year. They have about $22M as of Jul 1st so they need a bridge loan or financing tout suite.

The real need is some/ any direction from management on what the fk they are going to do with money other than preclinical trials as they will need 3 years of cash to get to partner those very risky molecules. Look what apparently happened to 4050 and 4547, the backbone of their small molecule program!! Liminal took years to choose IPF and hyperglycademia as their Phase 2 trial candidates and then they're gone even after some "success" in previous open label phase 2 trials.

newcamo, where are any details on the plans except voucher money will increase share price? It's known information already baked into the price! The market has known for over a month!! 

Newcamo wrote:

Weird that its LMNL that is hiring production employes and not kedrion.... dont ask stockbaboon, he will tell u you're drunk and they're not jobs:))

 https://liminalbiosciences.com/careers/laval/


<< Previous
Bullboard Posts
Next >>